Subtopic Deep Dive

M1/M2 Macrophage Polarization in Sepsis
Research Guide

What is M1/M2 Macrophage Polarization in Sepsis?

M1/M2 macrophage polarization in sepsis refers to the shift of macrophages from pro-inflammatory M1 to anti-inflammatory M2 phenotypes during sepsis-induced immune dysregulation.

Classical M1 macrophages produce pro-inflammatory cytokines like TNF-α and IL-6, while alternative M2 macrophages promote resolution via IL-10 and TGF-β. In sepsis, this polarization imbalance contributes to initial hyperinflammation followed by immunosuppression (Cuenca et al., 2010, 330 citations). Over 10 papers from the list link myeloid cells, including MDSCs related to macrophage function, to sepsis pathology.

Curated Papers

Key Challenges

Why It Matters

Targeting M1/M2 rebalancing in sepsis could reduce mortality from hyperinflammation and secondary infections. Cuenca et al. (2010) showed myeloid-derived suppressor cells (MDSCs), tied to M2-like suppression, paradoxically expand in sepsis, worsening outcomes. Bronte et al. (2016, 2630 citations) standardized MDSC nomenclature, aiding biomarker identification for therapies. Orihuela et al. (2015, 1954 citations) detailed metabolic shifts in M1/M2 polarization, relevant to sepsis metabolic reprogramming.

Key Research Challenges

Heterogeneity in MDSC Identification

MDSCs exhibit variable markers overlapping with M1/M2 macrophages, complicating sepsis studies. Bronte et al. (2016) proposed nomenclature standards, yet Veglia et al. (2021, 1631 citations) highlight increasing myeloid diversity. Standardization remains inconsistent across sepsis models.

Paradoxical MDSC Roles in Sepsis

MDSCs suppress early inflammation but exacerbate immunosuppression in sepsis. Cuenca et al. (2010) demonstrated their expansion in trauma/sepsis models with dual pro- and anti-inflammatory effects. Therapeutic targeting risks disrupting immune balance.

Metabolic Reprogramming Mechanisms

M1 relies on glycolysis while M2 uses oxidative phosphorylation, altered in sepsis. Orihuela et al. (2015) linked microglial M1/M2 metabolism to inflammation, applicable to sepsis macrophages. Interventions targeting metabolism lack specificity.

Essential Papers

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

Vincenzo Bronte, Sven Brandau, Shu‐Hsia Chen et al. · 2016 · Nature Communications · 2.6K citations

Abstract Myeloid-derived suppressor cells (MDSCs) have emerged as major regulators of immune responses in cancer and other pathological conditions. In recent years, ample evidence supports key cont...

Microglial <scp>M1/M2</scp> polarization and metabolic states

Rubén Orihuela, Christopher A. McPherson, G. Jean Harry · 2015 · British Journal of Pharmacology · 2.0K citations

Microglia are critical nervous system‐specific immune cells serving as tissue‐resident macrophages influencing brain development, maintenance of the neural environment, response to injury and repai...

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity

Filippo Veglia, Emilio Sanseviero, Dmitry I. Gabrilovich · 2021 · Nature reviews. Immunology · 1.6K citations

Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer

Kai Li, Houhui Shi, Benxia Zhang et al. · 2021 · Signal Transduction and Targeted Therapy · 791 citations

Inflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments

Li Zuo, Evan R. Prather, Mykola Stetskiv et al. · 2019 · International Journal of Molecular Sciences · 494 citations

It has been proposed that a chronic state of inflammation correlated with aging known as inflammaging, is implicated in multiple disease states commonly observed in the elderly population. Inflamma...

Pulmonary macrophages: key players in the innate defence of the airways

Adam J. Byrne, Sara A. Mathie, Lisa G. Gregory et al. · 2015 · Thorax · 476 citations

Macrophages are the most numerous immune-cells present in the lung environment under homoeostatic conditions and are ideally positioned to dictate the innate defence of the airways. Pulmonary macro...

Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Deficiency Attenuates Phagocytic Activities of Microglia and Exacerbates Ischemic Damage in Experimental Stroke

Masahito Kawabori, Rachid Kacimi, Tiina M. Kauppinen et al. · 2015 · Journal of Neuroscience · 365 citations

Clearing cellular debris after brain injury represents an important mechanism in regaining tissue homeostasis and promoting functional recovery. Triggering receptor expressed on myeloid cells-2 (TR...

Reading Guide

Foundational Papers

Start with Cuenca et al. (2010) for MDSC paradox in sepsis/trauma, then Bronte et al. (2016) for myeloid nomenclature standards essential for polarization studies.

Recent Advances

Veglia et al. (2021, 1631 citations) on myeloid diversity; Li et al. (2021, 791 citations) on MDSCs as therapeutic targets.

Core Methods

Flow cytometry (Bronte 2016), metabolic assays (Orihuela 2015), MDSC suppression assays (Cuenca 2010).

How PapersFlow Helps You Research M1/M2 Macrophage Polarization in Sepsis

Discover & Search

Research Agent uses searchPapers and exaSearch to find Cuenca et al. (2010) on MDSC roles in sepsis, then citationGraph reveals Bronte et al. (2016) standards and findSimilarPapers uncovers Veglia et al. (2021) on myeloid diversity.

Analyze & Verify

Analysis Agent applies readPaperContent to extract metabolic shifts from Orihuela et al. (2015), verifies claims with CoVe against Cuenca et al. (2010), and uses runPythonAnalysis for statistical comparison of cytokine data across papers with GRADE scoring for evidence strength.

Synthesize & Write

Synthesis Agent detects gaps in MDSC-sepsis interventions via contradiction flagging between Cuenca (2010) and Veglia (2021), while Writing Agent uses latexEditText, latexSyncCitations for Cuenca/2010, and latexCompile to generate review sections with exportMermaid for M1/M2 pathway diagrams.

Use Cases

"Extract cytokine expression data from M1/M2 papers in sepsis and plot glycolysis vs. OXPHOS shifts."

Research Agent → searchPapers('M1 M2 sepsis cytokines') → Analysis Agent → readPaperContent(Orihuela 2015) + runPythonAnalysis(pandas/matplotlib for metabolic stats) → matplotlib plot of shifts.

"Write LaTeX section on MDSC polarization in sepsis with citations."

Synthesis Agent → gap detection(Cuenca 2010, Bronte 2016) → Writing Agent → latexEditText(draft) → latexSyncCitations → latexCompile → PDF with M1/M2 figure.

"Find GitHub repos analyzing MDSC data from sepsis studies."

Research Agent → searchPapers('MDSC sepsis') → Code Discovery: paperExtractUrls(Cuenca 2010) → paperFindGithubRepo → githubRepoInspect → repo with flow cytometry analysis scripts.

Automated Workflows

Deep Research workflow scans 50+ papers via searchPapers on 'M1 M2 sepsis MDSC', structures report with citationGraph linking Cuenca (2010) to recent advances. DeepScan applies 7-step CoVe verification to Orihuela (2015) metabolism claims against Bronte (2016) standards. Theorizer generates hypotheses on metabolic interventions from Veglia (2021) diversity insights.

Try Doxa for M1/M2 Macrophage Polarization in Sepsis Research

Frequently Asked Questions

What defines M1/M2 macrophage polarization in sepsis?

M1 is pro-inflammatory (TNF-α, IL-6, glycolysis), M2 anti-inflammatory (IL-10, OXPHOS); sepsis shifts cause hyperinflammation then suppression (Orihuela et al., 2015; Cuenca et al., 2010).

What methods study this polarization?

Flow cytometry for markers, qPCR for cytokines, Seahorse assays for metabolism; MDSC standards use Bronte et al. (2016) guidelines (Veglia et al., 2021).

What are key papers?

Cuenca et al. (2010, 330 citations) on MDSC paradox in sepsis; Bronte et al. (2016, 2630 citations) nomenclature; Orihuela et al. (2015, 1954 citations) M1/M2 metabolism.

What open problems exist?

Specific MDSC targeting without immune collapse; metabolic intervention specificity; bridging microglial to peripheral macrophage models in sepsis (Veglia et al., 2021).